Published in J Cardiovasc Pharmacol on January 01, 1995
Endothelin. Pharmacol Rev (2016) 0.95
Acute effect of a dual ETA-ETB receptor antagonist on pulmonary arterial vasculature in preterm lamb fetuses with surgically induced diaphragmatic hernia. Pediatr Surg Int (2010) 0.78
Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography. Circulation (2002) 4.43
The Concise Guide to PHARMACOLOGY 2013/14: overview. Br J Pharmacol (2013) 2.48
Orphan-receptor ligand human urotensin II: receptor localization in human tissues and comparison of vasoconstrictor responses with endothelin-1. Br J Pharmacol (2000) 1.78
Characterization and localization of endothelin receptor subtypes in the human atrioventricular conducting system and myocardium. Circ Res (1993) 1.56
ETA receptor-mediated constrictor responses to endothelin peptides in human blood vessels in vitro. Br J Pharmacol (1995) 1.48
[(125)I]-(Pyr(1))Apelin-13 is a novel radioligand for localizing the APJ orphan receptor in human and rat tissues with evidence for a vasoconstrictor role in man. Br J Pharmacol (2001) 1.40
Chemokine receptor CCR5: from AIDS to atherosclerosis. Br J Pharmacol (2011) 1.29
Novel ligands BQ123 and BQ3020 characterize endothelin receptor subtypes ETA and ETB in human kidney. Kidney Int (1993) 1.22
Characterization of two new ETB selective radioligands, [125I]-BQ3020 and [125I]-[Ala1,3,11,15]ET-1 in human heart. Br J Pharmacol (1992) 1.17
Effects of an ET1-receptor antagonist, FR139317, on regional haemodynamic responses to endothelin-1 and [Ala11,15]Ac-endothelin-1 (6-21) in conscious rats. Br J Pharmacol (1994) 1.15
Endothelin-1 mRNA is widely expressed in porcine and human tissues. J Clin Invest (1990) 1.13
[125I-His(9)]-ghrelin, a novel radioligand for localizing GHS orphan receptors in human and rat tissue: up-regulation of receptors with athersclerosis. Br J Pharmacol (2001) 1.11
Kisspeptins: a multifunctional peptide system with a role in reproduction, cancer and the cardiovascular system. Br J Pharmacol (2007) 1.11
Depressor and regionally-selective vasodilator effects of human and rat urotensin II in conscious rats. Br J Pharmacol (2001) 1.10
Endothelin peptide and receptors in human atherosclerotic coronary artery and aorta. Circ Res (1996) 1.04
Vasoconstrictor endothelin receptors characterized in human renal artery and vein in vitro. Br J Pharmacol (1994) 1.01
Presence of messenger ribonucleic acid for endothelin-1, endothelin-2, and endothelin-3 in human endometrium and a change in the ratio of ETA and ETB receptor subtype across the menstrual cycle. J Clin Endocrinol Metab (1992) 1.00
Effect of in vivo fetal infusion of dexamethasone at 0.75 GA on fetal ovine resistance artery responses to ET-1. Am J Physiol Regul Integr Comp Physiol (2001) 1.00
Secretory pathways in endothelin synthesis. Br J Pharmacol (1999) 0.98
Human endothelial cell storage granules: a novel intracellular site for isoforms of the endothelin-converting enzyme. Circ Res (1998) 0.97
Anatomical localization and pharmacological activity of mature endothelins and their precursors in human vascular tissue. J Hypertens (1992) 0.95
Evidence using immunoelectron microscopy for regulated and constitutive pathways in the transport and release of endothelin. J Cardiovasc Pharmacol (1998) 0.95
Thromboxane receptor density is increased in human cardiovascular disease with evidence for inhibition at therapeutic concentrations by the AT(1) receptor antagonist losartan. Br J Pharmacol (2001) 0.93
Emerging pharmacology and physiology of neuromedin U and the structurally related peptide neuromedin S. Br J Pharmacol (2009) 0.93
Evaluation of translocator protein quantification as a tool for characterising macrophage burden in human carotid atherosclerosis. Atherosclerosis (2009) 0.93
Comparison of the vasoconstrictor effects of rizatriptan and sumatriptan in human isolated cranial arteries: immunohistological demonstration of the involvement of 5-HT1B-receptors. Br J Clin Pharmacol (1998) 0.93
Endothelin receptors in human coronary artery and aorta. Br J Pharmacol (1996) 0.92
Endothelin converting enzyme (ECE) activity in human vascular smooth muscle. Br J Pharmacol (1997) 0.90
Secretion of endothelin-1 and endothelin-3 by human cultured vascular smooth muscle cells. Br J Pharmacol (1995) 0.89
Endothelin receptor subtypes and their functional relevance in human small coronary arteries. Br J Pharmacol (1998) 0.89
Characterization of the endothelin receptor selective agonist, BQ3020 and antagonists BQ123, FR139317, BQ788, 50235, Ro462005 and bosentan in the heart. Br J Pharmacol (1996) 0.89
Physiological antagonism of endothelin-1 in human conductance and resistance coronary artery. Br J Pharmacol (2001) 0.89
The increase in human plasma immunoreactive endothelin but not big endothelin-1 or its C-terminal fragment induced by systemic administration of the endothelin antagonist TAK-044. Br J Pharmacol (1996) 0.89
Alternatively spliced mRNAs for human endothelin-2 and their tissue distribution. Biochem Biophys Res Commun (1993) 0.88
Endothelial cell-specific ETB receptor knockout: autoradiographic and histological characterisation and crucial role in the clearance of endothelin-1. Can J Physiol Pharmacol (2010) 0.88
Evidence for intracellular endothelin-converting enzyme-2 expression in cultured human vascular endothelial cells. Circ Res (1999) 0.88
Endothelin receptor antagonism in patients with chronic heart failure. Cardiovasc Res (2000) 0.87
A quantitative 'in-situ' hybridization method using computer-assisted image analysis. Validation and measurement of atrial-natriuretic-factor mRNA in the rat heart. Biochem J (1989) 0.87
Characterization of endothelin isoforms in human heart: endothelin-2 demonstrated. J Cardiovasc Pharmacol (1993) 0.87
Blockade and reversal of endothelin-induced constriction in pial arteries from human brain. Stroke (1999) 0.87
Nitric oxide-mediated modulation of the endothelin-1 signalling pathway in the human cardiovascular system. Br J Pharmacol (2001) 0.87
Failure of BQ123, a more potent antagonist of sarafotoxin 6b than of endothelin-1, to distinguish between these agonists in binding experiments. Br J Pharmacol (1996) 0.86
Vasoconstrictor activity of novel endothelin peptide, ET-1(1 - 31), in human mammary and coronary arteries in vitro. Br J Pharmacol (2001) 0.86
Selectivity of [125I]-PD151242 for human, rat and porcine endothelin ETA receptors in the heart. Br J Pharmacol (1995) 0.86
Affinity and selectivity of PD156707, a novel nonpeptide endothelin antagonist, for human ET(A) and ET(B) receptors. J Pharmacol Exp Ther (1997) 0.86
Characterization of the binding of endothelin ETB selective ligands in human and rat heart. Br J Pharmacol (1996) 0.85
Endothelin@25 - new agonists, antagonists, inhibitors and emerging research frontiers: IUPHAR Review 12. Br J Pharmacol (2014) 0.85
Endothelin ETA receptor expression in human cerebrovascular smooth muscle cells. Br J Pharmacol (1995) 0.85
Expression of endothelin peptides and mRNA in the human heart. Clin Sci (Lond) (1996) 0.85
Discovery of recently adopted orphan receptors for apelin, urotensin II, and ghrelin identified using novel radioligands and functional role in the human cardiovascular system. Can J Physiol Pharmacol (2002) 0.85
Endothelin expression in the uterus. J Steroid Biochem Mol Biol (1995) 0.84
Endothelin receptor expression and pharmacology in human saphenous vein graft. Br J Pharmacol (1999) 0.84
Epidermal growth factor in human endometrium: proliferative effects in culture and immunocytochemical localization in normal and endometriotic tissues. Hum Reprod (1991) 0.84
Quantification of mRNA in human tissue using fluorescent nested reverse-transcriptase polymerase chain reaction. Anal Biochem (1994) 0.84
Localization of endothelin receptors in human uterus throughout the menstrual cycle. Mol Hum Reprod (1996) 0.84
Localization of endothelin peptides in human kidney. Kidney Int (1996) 0.84
Phosphoramidon inhibition of the in vivo conversion of big endothelin-1 to endothelin-1 in the human forearm. Br J Pharmacol (1995) 0.83
Expression of endothelin(A) receptors in human gliomas and meningiomas, with high affinity for the selective antagonist PD156707. Neurosurgery (1998) 0.83
Characterization of endothelin receptors in human brain cortex, gliomas, and meningiomas. J Cardiovasc Pharmacol (1995) 0.83
Endothelin: progress in pharmacology and physiology. Trends Pharmacol Sci (1993) 0.83
Relative contribution of endothelin A and endothelin B receptors to vasoconstriction in small arteries from human heart and brain. J Cardiovasc Pharmacol (1998) 0.82
Human kidney: endothelin isoforms detected by HPLC with radioimmunoassay and receptor subtypes detected using ligands BQ123 and BQ3020. J Cardiovasc Pharmacol (1993) 0.82
Differential distribution of endothelin receptor subtypes in placentae from normal and growth-restricted pregnancies. Placenta (1997) 0.82
Effects of phosphoramidon and pepstatin A on the secretion of endothelin-1 and big endothelin-1 by human umbilical vein endothelial cells: measurement by two-site enzyme-linked immunosorbent assays. Clin Sci (Lond) (1994) 0.82
ETA and ETB endothelin receptors in human myometrium characterized by the subtype selective ligands BQ123, BQ3020, FR139317 and PD151242. J Endocrinol (1995) 0.81
Localization of immunoreactive endothelin and proendothelin in the human lung. Pulm Pharmacol (1992) 0.81
Maternal dexamethasone increases endothelin-1 sensitivity and endothelin a receptor expression in ovine foetal placental arteries. Placenta (2003) 0.81
Regulation of endothelin receptor expression in vascular smooth-muscle cells. J Cardiovasc Pharmacol (1995) 0.81
Endothelin-like immunoreactivity in human endometrium. J Reprod Fertil (1992) 0.81
Endothelin-A-receptors in human aorta and pulmonary arteries are downregulated in patients with cardiovascular disease: an adaptive response to increased levels of endothelin-1? J Cardiovasc Pharmacol (2000) 0.81
Myricerone caffeoyl ester (50-235) is a non-peptide antagonist selective for human ETA receptors. J Hypertens (1994) 0.81
Increased response to big endothelin-1 in atherosclerotic human coronary artery: functional evidence for up-regulation of endothelin-converting enzyme activity in disease. Br J Pharmacol (1998) 0.80
Identification of endothelin-1, endothelin-2 and endothelin-3 in human endometrium. J Reprod Fertil (1993) 0.80
Characterization of the snake venom ligand [125I]-DNP binding to natriuretic peptide receptor-A in human artery and potent DNP mediated vasodilatation. Br J Pharmacol (2006) 0.80
No alteration in vasoconstrictor endothelin-B-receptor density or function in human coronary artery disease. J Cardiovasc Pharmacol (2000) 0.79
The endothelin peptides ET-1, ET-2, ET-3 and sarafotoxin S6b are co-mitogenic with platelet-derived growth factor for vascular smooth muscle cells. Atherosclerosis (1990) 0.79
Endothelin-2 mRNA splice variants detected by RT-PCR in cultured human vascular smooth muscle and endothelial cells. J Cardiovasc Pharmacol (1993) 0.78
Delineation of endothelin receptors in human left ventricular smooth-muscle cells. J Cardiovasc Pharmacol (1995) 0.78
Changes in ET(A)-, AT1- and AT2-receptors in the phenotypically transformed intimal smooth muscle layer of human atherosclerotic coronary arteries. J Cardiovasc Pharmacol (2000) 0.78
Localization and endogenous concentration of endothelin-like immunoreactivity in human placenta. J Endocrinol (1991) 0.78
Measurement of C-terminal fragment of big endothelin-1: a novel method for assessing the generation of endothelin-1 in humans. J Cardiovasc Pharmacol (1995) 0.78
Syntheses of the first endothelin-A- and -B-selective radioligands for positron emission tomography. J Cardiovasc Pharmacol (2000) 0.77
PD156707: a potent antagonist of endothelin-1 in human diseased coronary arteries and vein grafts. J Cardiovasc Pharmacol (1998) 0.77
Distribution of endothelin receptors in atherosclerotic human coronary arteries. J Cardiovasc Pharmacol (1995) 0.77
Biogenic amines in the brain of the honeybee, Apis mellifera. Cell Tissue Res (1983) 0.77
Endothelin and the human kidney: a potential target for new drugs. Nephrol Dial Transplant (1994) 0.77
Novel nitric oxide donors reverse endothelin-1-mediated constriction in human blood vessels. J Cardiovasc Pharmacol (2000) 0.77
Endothelin peptide and converting enzymes in human endothelium. J Cardiovasc Pharmacol (1998) 0.77
Cerebellar neurons and glia respond differentially to endothelins and sarafotoxin S6b. Brain Res (1992) 0.76
The haemodynamic effects of iodinated water soluble radiographic contrast media: a review. Eur J Radiol (1998) 0.76
Detection of endothelin receptors in human coronary artery vascular smooth muscle cells but not endothelial cells by using electron microscope autoradiography. J Cardiovasc Pharmacol (1997) 0.76
Characterization of peptide and nonpeptide antagonists in human kidney. J Cardiovasc Pharmacol (1995) 0.76
In vitro enzymatic processing of radiolabelled big ET-1 in human kidney. Biochem Pharmacol (1998) 0.76
Comparative quantification of endothelin receptor mRNA in human kidney: new tools for direct investigation of human tissue. J Cardiovasc Pharmacol (1995) 0.76
Atrial natriuretic factor mRNA and binding sites in the adrenal gland. Biochem J (1990) 0.76
Endothelin-1 stimulates prostaglandin F2 alpha release from human endometrium. Prostaglandins Leukot Essent Fatty Acids (1991) 0.76
Autoradiographic study of endothelin receptors in human cerebral arteries. J Cardiovasc Pharmacol (1995) 0.75
Characterization of site-directed antisera against endothelin-converting enzymes. J Cardiovasc Pharmacol (1998) 0.75
Sex-related differences in the concentration of Met-enkephalin-like immunoreactivity in the nervous system of an insect, Schistocerca gregaria, revealed by radioimmunoassay. Brain Res (1986) 0.75